i think the SP wont move in a big way till safety and efficacy results are known.If results are proven positive a takeover or at least investment by big pharma should be guaranteed
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%